Deltec Asset Management LLC Makes New $987,000 Investment in Synopsys, Inc. $SNPS

Deltec Asset Management LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,000 shares of the semiconductor company’s stock, valued at approximately $987,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new position in Synopsys during the second quarter valued at approximately $647,964,000. Ameriprise Financial Inc. boosted its holdings in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares during the period. Ninety One UK Ltd purchased a new position in shares of Synopsys during the 3rd quarter valued at $249,851,000. Aspex Management HK Ltd increased its holdings in shares of Synopsys by 106.0% in the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after purchasing an additional 332,364 shares during the period. Finally, Vanguard Group Inc. raised its position in shares of Synopsys by 1.6% in the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after buying an additional 231,014 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Up 2.1%

Shares of SNPS opened at $525.18 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a 50 day simple moving average of $445.06 and a two-hundred day simple moving average of $504.57. The firm has a market cap of $100.48 billion, a P/E ratio of 65.73, a P/E/G ratio of 4.37 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period in the previous year, the business posted $3.40 EPS. The business’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Janet Lee sold 250 shares of the stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $510.00, for a total transaction of $127,500.00. Following the completion of the sale, the insider directly owned 12,209 shares in the company, valued at $6,226,590. This represents a 2.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on SNPS shares. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $605.00 to $560.00 in a research report on Tuesday, December 9th. BNP Paribas started coverage on Synopsys in a report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. KeyCorp upped their price objective on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Piper Sandler dropped their target price on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research report on Thursday, December 11th. Finally, Needham & Company LLC increased their price target on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Eleven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $562.13.

Read Our Latest Research Report on Synopsys

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.